ESC 365 - Vericiguat

HFA Premium Access

Vericiguat

Session: Where to position the new HF drugs?

Topic: Chronic Heart Failure

Speaker: Professor J. Butler (Dallas, US)

Event: Heart Failure 2023

Congress Presentation

Add to my library

About the speaker

Professor Javed Butler

Baylor Scott & White Health, Dallas (United States of America)

136 presentations

35 followers

3 more presentations in this session

Omecamtiv mecarbil

Speaker: Professor J. Teerlink (San Francisco, US)

Tafamidis and other therapies on the horizon for cardiac amyloid

Speaker: Doctor P. Garcia-Pavia (Majadahonda, ES)

Where to position the new HF drugs? – discussion

Access the full session

Where to position the new HF drugs?

Speakers: Professor J. Butler, Professor J. Teerlink, Doctor P. Garcia-Pavia

About the event

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

Congress

Related content

HFA Premium Access

Iron deficiency

22 May 2023

HFA Premium Access

Iron deficiency: detect and treat

20 May 2023

Open Access

2023 Focused update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure – Ask the Guidelines Task Force

27 August 2023

ESC 365 is supported by

novartis

Explore sponsored resources